References
- Ogden CL, Carroll MD, Curtin LR, et al Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006;295:1549–1555.
- Fisher SG, Fisher RI. The epidemiology of non-Hodgkin's lymphoma. Oncogene 2004;23:6524–6534.
- Renehan AG, Tyson M, Egger M, et al Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569–578.
- Bastarrachea J, Hortobagyi GN, Smith TL, et al Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann Intern Med 1994;120:18–25.
- Loi S, Milne RL, Friedlander ML, et al Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1686–1691.
- Meyerhardt JA, Catalano PJ, Haller DG, et al Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 2003;98:484–495.
- Jemal A, Siegel R, Ward E, et al Cancer statistics, 2007. CA Cancer J Clin 2007;57:43–66.
- Charlson ME, Pompei P, Ales KL, et al A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–383.
- A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993;329:987–994.
- World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. Tech Rep Series No. 854. Geneva: WHO; 1995.
- Cheson BD, Horning SJ, Coiffier B, et al Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999;17:1244.
- National Cancer Institute. Common toxicity criteria v2.0. Bethesda, MD: NCI; 1998.
- Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481.
- Hosmer DW, Lemeshow S. Applied survival analysis: regression modeling of time to event data. New York: Wiley; 1999.
- Cox D. Regression models and life tables. J R Stat Soc B 1972;34:187–220.
- Grambsch PM. Goodness-of-fit and diagnostics for proportional hazards regression models. Cancer Treat Res 1995;75:95–112.
- Landgren O, Andren H, Nilsson B, et al Risk profile and outcome in Hodgkin's lymphoma: is obesity beneficial? Ann Oncol 2005;16:838–840.
- Navarro WH, Loberiza FR Jr, Bajorunaite R, et al Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant 2006;12:541–551.
- Butturini AM, Dorey FJ, Lange BJ, et al Obesity and outcome in pediatric acute lymphoblastic leukemia. J Clin Oncol 2007;25:2063–2069.
- Lange BJ, Gerbing RB, Feusner J, et al Mortality in overweight and underweight children with acute myeloid leukemia. JAMA 2005;293:203–211.
- Flegal KM, Graubard BI, Williamson DF, et al Excess deaths associated with underweight, overweight, and obesity. JAMA 2005;293:1861–1867.
- Heiat A, Vaccarino V, Krumholz HM. An evidence-based assessment of federal guidelines for overweight and obesity as they apply to elderly persons. Arch Intern Med 2001;161:1194–1203.
- O'Brien JM Jr, Welsh CH, Fish RH, et al Excess body weight is not independently associated with outcome in mechanically ventilated patients with acute lung injury. Ann Intern Med 2004;140:338–345.
- Rosner GL, Hargis JB, Hollis DR, et al Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541. J Clin Oncol 1996;14:3000–3008.
- Colleoni M, Li S, Gelber RD, et al Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index. Lancet 2005;366:1108–1110.
- Griggs JJ, Sabel MS. Obesity and cancer treatment: weighing the evidence. J Clin Oncol 2008;26:4060–4062.
- Sparreboom A, Wolff AC, Mathijssen RH, et al Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese. J Clin Oncol 2007;25:4707–4713.
- Simons-Morton DG, Obarzanek E, Cutler JA. Obesity research–limitations of methods, measurements, and medications. JAMA 2006;295:826–828.